Comparisons of Left Ventricular Hypertrophy due to Essential Hypertension and Hypertrophic Non-Obstructive

Mareomi Hamada1, Sayuri Uga-Yamabe2, Shuntaro Ikeda3

  • 1Division of Cardiology, Uwajima City Hospital.

International Heart Journal
|November 12, 2025
PubMed

Insights

Essential hypertension (EH) and hypertrophic non-obstructive cardiomyopathy (HNCM) both cause left ventricular hypertrophy (LVH). HNCM shows more severe myocardial ischemia and distinct LVH distribution compared to EH.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Clinical Electrophysiology

Background:

  • Left ventricular hypertrophy (LVH) is a hallmark of both essential hypertension (EH) and hypertrophic non-obstructive cardiomyopathy (HNCM).
  • Understanding the differences in LVH severity and distribution between EH and HNCM is crucial for accurate diagnosis and management.

Purpose of the Study:

  • To compare the severity and distribution patterns of left ventricular hypertrophy (LVH) between patients with essential hypertension (EH) and hypertrophic non-obstructive cardiomyopathy (HNCM).
  • To investigate the correlation between electrocardiographic findings and echocardiographic parameters in these conditions.

Main Methods:

  • Included 44 patients with EH and 79 with HNCM, all exhibiting precordial negative T-waves (NTs) without LV heart failure.
  • Electrocardiographic assessments included SV1 + RV5 and maximum NT depth; echocardiography measured routine indices.
  • Analyzed interventricular septal thickness (IVST), LV posterior wall thickness (PWT), and LV mass index.

Main Results:

  • HNCM demonstrated greater SV1 + RV5 and maximum NT depth than EH, with a significantly steeper correlation slope (4.8x) in HNCM, indicating more severe myocardial ischemia.
  • Distinct NT distribution patterns were observed: V6 in EH, and V4/V5 in HNCM.
  • IVST/PWT ratio was significantly higher in HNCM (1.20 ± 0.35) than EH (0.91 ± 0.10); LV mass index was similar between groups.

Conclusions:

  • While LVH severity (mass index) is comparable, myocardial ischemia is more pronounced in HNCM than EH.
  • The distribution pattern of LVH and associated ECG markers differ significantly between EH and HNCM, aiding in differential diagnosis.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
380
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
695
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
451
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
488
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
394
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.7K